The Impact of Renal Dysfunction on Aprotinin Pharmacokinetics During Cardiopulmonary Bypass
- 1 November 1999
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 89 (5) , 1101-1107
- https://doi.org/10.1213/00000539-199911000-00006
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- The Effect of Chronic Renal Failure on Plasma Aprotinin Levels During Cardiac SurgeryAnesthesia & Analgesia, 1997
- Randomized, Placebo-Controlled, Double-Blind Study of an Ultra-Low-Dose Aprotinin Regimen in Reoperative and/or Complex Cardiac OperationsJournal of Cardiac Surgery, 1997
- Maintenance of Therapeutic Plasma Aprotinin Levels During Prolonged Cardiopulmonary Bypass Using a Large-Dose RegimenAnesthesia & Analgesia, 1996
- Aprotinin in primary valve replacement and reconstruction: A multicenter, double-blind, placebo-controlled trialThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Pharmacokinetics of aprotinin in two patients with chronic renal impairmentBritish Journal of Clinical Pharmacology, 1996
- Glomerular filtration and tubular absorption of the basic polypeptide aprotininActa Physiologica Scandinavica, 1994
- Predictability of creatinine clearance estimates in critically ill patientsCritical Care Medicine, 1993
- Platelet protection by low-dose aprotinin in cardiopulmonary bypass: Electron microscopic studyThe Annals of Thoracic Surgery, 1993
- Cardiopulmonary Bypass and the Pharmacokinetics of DrugsClinical Pharmacokinetics, 1989
- Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1987